Life Line Screening is the largest screening company for vascular diseases having screened over 8 million people. It is intended as a supplement to the regular healthcare of the patient that may have health risk factors. The type of screening to be done for each patient is based on the patient’s family health history, the patient’s personal medical history and the risk factors that are present.
Three types of preventive screenings are offered. The first is ultrasound screenings checking for aneurysms, arterial disease and the possible presence of osteoporosis. The second type of screening is finger-stick blood screening checking for cholesterol problems, possibility of diabetes, cardiovascular disease and any possible damage to the liver. The third type of screening available is limited electrocardiograph screening checking for an irregular heartbeat which could be an early indicator of stroke.
Dr. Andrew J. Manganaro is the Chief Medical Officer and National Medical Director of Life Line Screening. He is a vascular and cardiothoracic surgeon and has been for 25 years. Part of his duties to Life Line Screening is to be in charge of quality assurance and the research of the company. There are new screenings coming in the future. Life Line keeps current with all research in order to offer new screenings as they become available.
After witnessing debilitating results from vascular diseases, Dr. Manganaro has found that diseases could have been prevented for patients had they known that the potential existed. His belief in Life Line Screening comes from that knowledge. With a marketing campaign in place to bring attention to the screening available through Life Line Screening, more people are having the screenings done. The company’s database is used in peer reviewed medical journals and a large number of doctors support the screenings. The available screenings will continue to evolve and available database and medical literature contributions will grow with it.